Nucleotide-binding oligomerization domain-containing protein 2 (Nod2) modulates T1DM susceptibility by gut microbiota

Journal of Autoimmunity

Volumn 82, Issue , 2017, Pages 85-95

  Li, Yang yang ^a,b   Pearson, James A ^a   Chao, Chen ^a,c   Peng, Jian ^a   Zhang, Xiaojun ^a   Zhou, Zhiguang ^c   Liu, Yu ^b,d   Wong, F Susan ^e   Wen, Li ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d NANJING MEDICAL UNIVERSITY   (China)

^e CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Gut microbiota; Innate immunity; NOD; Nod2; Type 1 diabetes mellitus

Indexed keywords

BACTERIAL DNA; IMMUNOGLOBULIN A; INSULIN; INTERLEUKIN 10; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING PROTEIN 2; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; RNA 16S; UNCLASSIFIED DRUG; CARD15 PROTEIN, MOUSE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYTOKINE; SECRETORY IMMUNOGLOBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE PREDISPOSITION; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; ANIMAL; DENDRITIC CELL; DISEASE MODEL; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; B-LYMPHOCYTES; CYTOKINES; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN A, SECRETORY; MACROPHAGES; MICE, INBRED NOD; MICE, KNOCKOUT; NOD2 SIGNALING ADAPTOR PROTEIN; T-LYMPHOCYTE SUBSETS;

EID: 85020071394     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2017.05.007     Document Type: Article

References (36)

1. Tuomi, T., Santoro, N., Caprio, S., Cai, M., Weng, J., Groop, L., The many faces of diabetes: a disease with increasing heterogeneity. Lancet 383 (2014), 1084–1094.
2. Variation and trends in incidence of childhood diabetes in Europe. EURODIAB ACE study group. Lancet 355 (2000), 873–876.
3. Gillespie, K.M., Bain, S.C., Barnett, A.H., Bingley, P.J., Christie, M.R., Gill, G.V., et al. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 364 (2004), 1699–1700.
4. Bessaoud, K., Boudraa, G., Molinero de Ropolo, M., de Sereday, M., Marti, M.L., Moser, M., et al. Incidence and trends of childhood Type 1 diabetes worldwide 1990–1999. Diabet. Med. 23 (2006), 857–866.
5. Harjutsalo, V., Sjöberg, L., Tuomilehto, J., Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 371 (2008), 1777–1782.
6. Evertsen, J., Alemzadeh, R., Wang, X., Increasing incidence of pediatric type 1 diabetes mellitus in southeastern Wisconsin: relationship with body weight at diagnosis. Plos One, 4, 2009, e6873.
7. Ehehalt, S., Dietz, K., Willasch, A.M., Neu, A., Baden-Wuerttemberg Daibet, I., Epidemiological perspectives on type 1 diabetes in childhood and adolescence in Germany - 20 years of the baden-wurttemberg diabetes incidence registry (DIARY). Diabetes Care 33 (2010), 338–340.
8. Kim, H.S., Han, M.S., Chung, K.W., Kim, S., Kim, E., Kim, M.J., et al. Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes. Immunity 27 (2007), 321–333.
9. Wong, F.S., Hu, C., Zhang, L., Du, W., Alexopoulou, L., Flavell, R.A., et al. The role of Toll-like receptors 3 and 9 in the development of autoimmune diabetes in NOD mice. Ann. N. Y. Acad. Sci. 1150 (2008), 146–148.
10. Zhang, Y., Lee, A.S., Shameli, A., Geng, X., Finegood, D., Santamaria, P., et al. TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes. J. Immunol. 184 (2010), 5645–5653.
11. Kim, D.H., Lee, J.C., Lee, M.K., Kim, K.W., Lee, M.S., Treatment of autoimmune diabetes in NOD mice by Toll-like receptor 2 tolerance in conjunction with dipeptidyl peptidase 4 inhibition. Diabetologia 55 (2012), 3308–3317.
12. Gülden, E., Ihira, M., Ohashi, A., Reinbeck, A.L., Freudenberg, M.A., Kolb, H., et al. Toll-like receptor 4 deficiency accelerates the development of insulin-deficient diabetes in non-obese diabetic mice. PLoS One, 8, 2013, e75385.
13. Tai, N., Wong, F.S., Wen, L., TLR9 deficiency promotes CD73 expression in T cells and diabetes protection in nonobese diabetic mice. J. Immunol. 191 (2013), 2926–2937.
14. Wen, L., Ley, R.E., Volchkov, P.Y., Stranges, P.B., Avanesyan, L., Stonebraker, A.C., et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455 (2008), 1109–1113.
15. Hu, C., Ding, H., Li, Y., Pearson, J.A., Zhang, X., Flavell, R.A., et al. NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 11318–11323.
16. Kobayashi, K.S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Nuñez, G., et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307 (2005), 731–734.
17. Biswas, A., Liu, Y.J., Hao, L., Mizoguchi, A., Salzman, N.H., Bevins, C.L., et al. Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 14739–14744.
18. Ramanan, D., Tang, M.S., Bowcutt, R., Loke, P., Cadwell, K., Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal Bacteroides vulgatus. Immunity 41 (2014), 311–324.
19. Ogura, Y., Bonen, D.K., Inohara, N., Nicolae, D.L., Chen, F.F., Ramos, R., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001), 603–606.
20. Hugot, J.P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.P., Belaiche, J., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001), 599–603.
21. Divangahi, M., Mostowy, S., Coulombe, F., Kozak, R., Guillot, L., Veyrier, F., et al. NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J. Immunol. 181 (2008), 7157–7165.
22. Peng, J., Narasimhan, S., Marchesi, J.R., Benson, A., Wong, F.S., Wen, L., Long term effect of gut microbiota transfer on diabetes development. J. Autoimmun. 53 (2014), 85–94.
23. Harriman, G.R., Kunimoto, D.Y., Elliott, J.F., Paetkau, V., Strober, W., The role of IL-5 in IgA B cell differentiation. J. Immunol. 140 (1988), 3033–3039.
24. Shanahan, M.T., Carroll, I.M., Grossniklaus, E., White, A., von Furstenberg, R.J., Barner, R., et al. Mouse Paneth cell antimicrobial function is independent of Nod2. Gut 63 (2014), 903–910.
25. McDole, J.R., Wheeler, L.W., McDonald, K.G., Wang, B., Konjufca, V., Knoop, K.A., et al. Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine. Nature 483 (2012), 345–349.
26. Farache, J., Koren, I., Milo, I., Gurevich, I., Kim, K.W., Zigmond, E., et al. Luminal bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation. Immunity 38 (2013), 581–595.
27. Costa, F.R., Françozo, M.C., de Oliveira, G.G., Ignacio, A., Castoldi, A., Zamboni, D.S., et al. Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset. J. Exp. Med. 213 (2016), 1223–1239.
28. Ivanov, I.I., Atarashi, K., Manel, N., Brodie, E.L., Shima, T., Karaoz, U., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139 (2009), 485–498.
29. Russell, M.W., Brown, T.A., Claflin, J.L., Schroer, K., Mestecky, J., Immunoglobulin A-mediated hepatobiliary transport constitutes a natural pathway for disposing of bacterial antigens. Infect. Immun. 42 (1983), 1041–1048.
30. Jonard, P.P., Rambaud, J.C., Dive, C., Vaerman, J.P., Galian, A., Delacroix, D.L., Secretion of immunoglobulins and plasma proteins from the jejunal mucosa. Transport rate and origin of polymeric immunoglobulin A. J. Clin. Invest. 74 (1984), 525–535.
31. Phalipon, A., Cardona, A., Kraehenbuhl, J.P., Edelman, L., Sansonetti, P.J., Corthésy, B., Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo. Immunity 17 (2002), 107–115.
32. Turley, S.J., Lee, J.W., Dutton-Swain, N., Mathis, D., Benoist, C., Endocrine self and gut non-self intersect in the pancreatic lymph nodes. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 17729–17733.
33. Tai, N., Peng, J., Liu, F., Gulden, E., Hu, Y., Zhang, X., et al. Microbial antigen mimics activate diabetogenic CD8 T cells in NOD mice. J. Exp. Med. 213 (2016), 2129–2146.
34. Horai, R., Zárate-Bladés, C.R., Dillenburg-Pilla, P., Chen, J., Kielczewski, J.L., Silver, P.B., et al. Microbiota-dependent activation of an autoreactive T cell receptor provokes autoimmunity in an immunologically privileged site. Immunity 43 (2015), 343–353.
35. Pauleau, A.L., Murray, P.J., Role of nod2 in the response of macrophages to toll-like receptor agonists. Mol. Cell Biol. 23 (2003), 7531–7539.
36. Penny, H.A., Leeds, J.S., Kurien, M., Averginos, A., Hopper, A.D., Hadjivassiliou, M., et al. The relationship between inflammatory bowel disease and type 1 diabetes mellitus: a study of relative prevalence in comparison with population controls. J. Gastrointestin Liver Dis. 24 (2015), 125–126.